Postdoctoral Research Training in Biotherapy of Cancer

NIH RePORTER · NIH · T32 · $293,213 · view on reporter.nih.gov ↗

Abstract

Abstract This proposal is the third renewal for a T32 training program for the Division of Surgical Oncology at the University of Pittsburgh. The singular goal of this program is to prepare surgeons for a career as translational scientists in the field of biologic therapy of cancer. We will pursue this goal by providing the trainees with an immersive experience that will stress three core proficiencies necessary to be a successful translational scientist 1) Basic laboratory research skills. 2) Fundamental principles of clinical investigation 3) Pragmatic experience in clinical trial management. At the completion of this training program the surgical trainee will be uniquely prepared to bridge the gap between clinical and laboratory research. Our expectation is that this will enhance their ability to compete for positions and funding in their first faculty position. The applicant pool will include surgical residents (largely from University of Pittsburgh) who are interested in surgical oncology. In addition to a thorough and innovative training program, we also developed a comprehensive plan for training in responsible conduct of clinical research and methods for enhancing reproducibility. We have included an aggressive approach to recruitment and retention of under-represented minorities. Given the long and proven track record of our surgical oncology faculty in performing cutting edge translational research this program is uniquely positioned to fill an important societal gap in training and supporting surgeon scientists.

Key facts

NIH application ID
10934691
Project number
2T32CA113263-16A1
Recipient
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Principal Investigator
Udai S Kammula
Activity code
T32
Funding institute
NIH
Fiscal year
2024
Award amount
$293,213
Award type
2
Project period
2006-08-01 → 2029-06-30